Metraipolis › archive › dc_f5563fcf33e6

Overcoming immunotherapy resistance in triple-negative breast cancer: a critical review of mast cell plasticity, metabolic reprogramming, and organoid models — Europe PMC PMID:42266701

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42266701
DOI
10.3389/fimmu.2026.1774946
License (as archived)
solo-consultazione
Archived
2026-11-01T07:49:10.507Z
SHA-256 of the archived text
9c44f997c5d67f04a4b0971ad7095575a90c21dbac785d1ea7d5562d20d2026d
Stable URL of this page
https://metraipolis.com/documento/dc_f5563fcf33e6

How to cite

Overcoming immunotherapy resistance in triple-negative breast cancer: a critical review of mast cell plasticity, metabolic reprogramming, and organoid models — Europe PMC PMID:42266701 — Europe PMC (en), https://europepmc.org/article/MED/42266701 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f5563fcf33e6 (Metraipolis archive dc_f5563fcf33e6, sha256 9c44f997c5d67f04a4b0971ad7095575a90c21dbac785d1ea7d5562d20d2026d)
BibTeX
@misc{dcf5563fcf33e6,
  title = {Overcoming immunotherapy resistance in triple-negative breast cancer: a critical review of mast cell plasticity, metabolic reprogramming, and organoid models — Europe PMC PMID:42266701},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42266701},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f5563fcf33e6; sha256 9c44f997c5d67f04a4b0971ad7095575a90c21dbac785d1ea7d5562d20d2026d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42266701. Agents can read the archived copy with the MCP tool read_document.